Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Champions Oncology, Inc. (CSBR) vs MindWalk Holdings Corp. (HYFT)

Champions Oncology, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Champions Oncology, Inc. and MindWalk Holdings Corp. are of similar size ($68.9M and $66.9M). Champions Oncology, Inc. grew revenue faster over the last twelve months: 6.65% against −27.0%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −105.1%) and the lower return on invested capital (−626.2% vs −464.6%). Across the 18 metrics below, Champions Oncology, Inc. leads on 13 and MindWalk Holdings Corp. on 5.

Valuation

Metric CSBR HYFT Biotechnology median
P/E n/m n/m 7.88
P/S 1.12 5.51 11.47
P/B 15.27 13.05 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 226.74 n/m 0.74
EV/Sales 1.16 5.42 10.73
Earnings yield (1.63%) (19.07%) (28.84%)
Free cash flow yield (8.98%) (13.93%) (23.03%)

Profitability

Metric CSBR HYFT Biotechnology median
Gross margin 49.82% 60.81% 65.16%
Operating margin (1.68%) (103.99%) 0.00%
Net margin (1.87%) (105.06%) 0.00%
Free cash flow margin (10.08%) (76.79%) 0.00%
Return on equity (28.38%) (122.85%) (57.72%)
Return on assets (3.56%) (58.55%) (49.22%)
Return on invested capital (626.23%) (464.59%) 0.00%

Growth

Metric CSBR HYFT Biotechnology median
Revenue growth (TTM) 6.65% (26.99%) 5.64%
EPS growth (last fiscal year) (124.24%) 66.15% —
Revenue growth, 5-year CAGR 7.68% (3.83%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR HYFT Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 1.03 1.84 4.73
Net debt to EBITDA (20.56) 0.62 0.96

Dividend

Metric CSBR HYFT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CSBR HYFT Biotechnology median
Market cap 68.90m 66.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack